In hepatocellular carcinoma (HCC) cells, CR-1 binds and stabilizes DVL3, helped by the concomitant binding of the Frizzled receptor FZD7 and the transmembrane lipoprotein LRP6, resulting in a more sustained signal from the Wnt/β-catenin axis. Here, CR1 is linked to hepatocellular carcinoma.